We propose to use a rodent model of age-related physical decline to conduct pre-clinical testing of two promising pharmacologic interventions with the potential to forestall frailty-associated physical decline, angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARE) and to study pathophysiologic changes postulated to play important roles in frailty. The current PA (FRAILTY IN OLD AGE: PATHOPHYSIOLOGY AND INTERVENTIONS:PAS-03-122) recommends the preclinical testing of promising interventions with the potential to forestall frailty-associated physical decline such as ACEi. Preliminary studies presented in this application suggest that ACEi use in aged rats attenuates age-related declines in physical performance and is associated with a reduction in total body fat mass. This is of great interest in the context of frailty given the growing body of evidence linking differences in fat mass and fat distribution to muscle function and physical decline. However, it is unclear how ACEi may contribute to declining performance or whether the effects seen with ACEi are mediated by the angiotensin receptor or other mechanisms. Long-term clinical trials in hypertensive persons using either ARBs, which only block the action of ANGII by antagonizing the AT1 receptor, or ACEi have shown that both treatments reduce the risk for the development of metabolic abnormalities in fat and muscle associated with type II diabetes. There is still some debate as to how each intervention affects these changes. Alterations in either pathway have profound metabolic consequences, most notably in conditions of hypertension, obesity and insulin resistance. One primary and two secondary aims will be addressed in this application: 1) Determine the effect of Enalapril and Losartan vs. saline control treatment on physical performance across a portion of the lifespan of male Brown Norway x F344 rats; 2) Determine the time course of age-related changes and the effect of Enalapril vs. Losartan treatment on whole body insulin sensitivity and glucose tolerance and changes in adipose tissue and skeletal muscle physiology; 3) relate these findings to declining physical performance. These data will lay the groundwork for characterizing the role of long-term ACEi and ARB treatment in reversing these changes, as well as provide preliminary data for planning randomized clinical trials in humans for the prevention of the age related decline in physical function.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG024526-04
Application #
7462273
Study Section
Special Emphasis Panel (ZRG1-ASG (01))
Program Officer
Eldadah, Basil A
Project Start
2005-09-15
Project End
2010-07-31
Budget Start
2008-08-15
Budget End
2009-07-31
Support Year
4
Fiscal Year
2008
Total Cost
$282,254
Indirect Cost
Name
University of Florida
Department
Other Health Professions
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Picca, Anna; Sirago, Giuseppe; Pesce, Vito et al. (2018) Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart. Biomolecules 8:
Marzetti, Emanuele; Calvani, Riccardo; DuPree, Jameson et al. (2013) Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle. Age (Dordr) 35:1061-75
Carter, Christy S; Marzetti, Emanuele; Leeuwenburgh, Christiaan et al. (2012) Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia. J Gerontol A Biol Sci Med Sci 67:17-27
Morgan, Drake; Mitzelfelt, Jeremiah D; Koerper, Lorraine M et al. (2012) Effects of morphine on thermal sensitivity in adult and aged rats. J Gerontol A Biol Sci Med Sci 67:705-13
Moningka, Natasha C; Sasser, Jennifer M; Croker, Byron et al. (2011) Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase. Mech Ageing Dev 132:1-7
Carter, Christy S; Giovannini, Silvia; Giovaninni, Silvia et al. (2011) Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats. Age (Dordr) 33:167-83
Kim, Ji Min; Heo, Hyoung-Sam; Choi, Yeon Ja et al. (2011) Inhibition of NF-?B-induced inflammatory responses by angiotensin II antagonists in aged rat kidney. Exp Gerontol 46:542-8
Pahor, Marco (2011) Consideration of insurance reimbursement for physical activity and exercise programs for patients with diabetes. JAMA 305:1808-9
Mitzelfelt, Jeremiah D; Dupree, Jameson P; Seo, Dong-oh et al. (2011) Effects of chronic fentanyl administration on physical performance of aged rats. Exp Gerontol 46:65-72
Marzetti, Emanuele; Hwang, Judy C Y; Lees, Hazel A et al. (2010) Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta 1800:235-44

Showing the most recent 10 out of 17 publications